| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/31/1997 | WO1997049762A1 Hydrophobic polymer dispersion and process for the preparation thereof |
| 12/31/1997 | WO1997049736A2 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | WO1997049675A1 Per(poly)fluorinated polyoxyethylated carbamates |
| 12/31/1997 | WO1997049419A1 Ophthalmic drug compositions |
| 12/31/1997 | WO1997049405A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | WO1997049402A1 Sustained release sufentanil compositions |
| 12/31/1997 | WO1997049394A2 Sold oral dosage forms of valsartan |
| 12/31/1997 | WO1997049392A1 A composition of enalapril and losartan |
| 12/31/1997 | WO1997049391A1 Methods for providing safe local anesthesia |
| 12/31/1997 | WO1997049387A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | WO1997049386A1 Oral delivery of peptides |
| 12/31/1997 | WO1997049385A1 Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients |
| 12/31/1997 | WO1997049384A1 Hot-melt extrudable pharmaceutical formulation |
| 12/31/1997 | WO1997049383A1 Antibacterial composition |
| 12/31/1997 | WO1997049382A1 Iontophoretic delivery devices for antagonists of glycoprotein iib/iiia |
| 12/31/1997 | WO1997049335A1 Novel radiopharmaceutical compositions and matrices and uses thereof |
| 12/31/1997 | WO1997045091A3 Sustained release oxycodone formulations with no fed/fast effect |
| 12/31/1997 | WO1997038726A3 Hydrophobic carbomer complex compositions |
| 12/31/1997 | CN1169115A Liposomes containing a corticosteroid |
| 12/31/1997 | CN1169114A Sequestration agents |
| 12/31/1997 | CN1169113A Solubilisation aids for hydrophilic macromolecules |
| 12/31/1997 | CN1169109A 稳定的油包水乳状液体系 Stable oil-in-water emulsion system |
| 12/31/1997 | CN1168793A Injection adhesion and method for preparing same |
| 12/31/1997 | CN1168792A Matrix table allowing prolonged release of sodium salt of tianeptine after administration by oral route |
| 12/31/1997 | CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen |
| 12/31/1997 | CA2258851A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | CA2258744A1 Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| 12/31/1997 | CA2258322A1 Per(poly)fluorinated polyoxyethylated carbamates |
| 12/31/1997 | CA2258199A1 Topical gel composition containing a combination of a nsaid and a xanthine derivative |
| 12/31/1997 | CA2257946A1 A composition of enalapril and losartan |
| 12/30/1997 | USRE35706 Administering as viricides and antitumor agents |
| 12/30/1997 | US5703127 Administering methionine with a sweetener |
| 12/30/1997 | US5703126 Amphiphilic fluorine derivatives with telomeric structures |
| 12/30/1997 | US5703117 Hydrolysis-promoting hydrophobic taxane derivatives |
| 12/30/1997 | US5703080 Method for stabilizing duocarmycin derivatives |
| 12/30/1997 | US5703058 Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
| 12/30/1997 | US5703055 Generation of antibodies through lipid mediated DNA delivery |
| 12/30/1997 | US5703051 Therapeutic uses of melanin |
| 12/30/1997 | US5703039 Chimeric toxins |
| 12/30/1997 | US5702880 Aqueous solution comprising specified concentrations of potassium, sodium, magnesium, calcium and chloride ions, hydroxyethyl starch, glucose, lactate buffer |
| 12/30/1997 | US5702727 Compositions and methods for the oral delivery of active agents |
| 12/30/1997 | US5702725 Hydromorphone therapy |
| 12/30/1997 | US5702724 Compressing inclusion compound containing diclofenac or salt and cyclodextrin into tablets |
| 12/30/1997 | US5702723 Active material internal layer, antacid coating, external coating |
| 12/30/1997 | US5702722 Three-dimensional expanded structure; drug delivery |
| 12/30/1997 | US5702721 Multilayer |
| 12/30/1997 | US5702720 Involving an acrylate or mathacrylate based copolymer, a skin penetration enhancer, a polyvinylpyrrolidone polymer and flurbiprofen drug; antiinflamatory, analgesic and antipyretic agent |
| 12/30/1997 | US5702719 Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
| 12/30/1997 | US5702717 Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers |
| 12/30/1997 | US5702716 Polymeric compositions useful as controlled release implants |
| 12/30/1997 | US5702711 Method for enhancing the rate of skin permeation of lactic acid through use of the L-enantiomer |
| 12/30/1997 | US5702709 Containing organophilic clay |
| 12/30/1997 | US5702687 Gum base, organic encapsulated alkali metal bicarbonate, plaque-inhibitor, water soluble bulking agent, colorant, abrasive, surfactant, fluoridating agent, glycerin or lecithin |
| 12/30/1997 | CA2085231C Process for the preparation of shaped, compressed controlled-release unit-dosage forms, and the compressed unit-dosage forms thus obtained |
| 12/30/1997 | CA2060833C Analgesic composition containing ibuprofen |
| 12/30/1997 | CA2032475C Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines |
| 12/30/1997 | CA2030237C Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist |
| 12/29/1997 | EP0814087A2 Partially lyophilized fructose-1,6-diphosphate (FDP) for injection into humans |
| 12/29/1997 | EP0814080A1 Squalene synthetase inhibitors |
| 12/29/1997 | EP0813904A2 Process for preparing salts of acid groups containing pharmaceutical actives |
| 12/29/1997 | EP0813879A2 Drug administration composition for iontophoresis |
| 12/29/1997 | EP0813876A1 Cyclosporin-containing soft capsule preparations |
| 12/29/1997 | EP0813865A1 Drug patch |
| 12/29/1997 | EP0813864A1 Effervescent system for effervescent tablets and granulates and processes for preparing the effervescent system |
| 12/29/1997 | EP0813863A2 A method for the preparation of stable aqueous suspensions, useful in pharmaceutical compositions |
| 12/29/1997 | EP0813859A2 Hair care sustained release composition |
| 12/29/1997 | EP0813817A2 Sugar-free hard coatings and a method for obtaining them |
| 12/29/1997 | EP0813424A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 12/29/1997 | EP0813423A1 Composition to ameliorate osteolysis and metastasis |
| 12/29/1997 | EP0813422A1 Compositions and methods for stimulating antibody class switching |
| 12/29/1997 | EP0813421A1 Liquid formulations for proteinic pharmaceuticals comprising at least 2 absorption enhancers |
| 12/29/1997 | EP0813413A1 Corticosteroid-containing pharmaceutical composition |
| 12/29/1997 | EP0813412A1 Gel for the local hormonotherapy of vaginal dryness |
| 12/29/1997 | EP0813407A1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 12/29/1997 | EP0813403A1 Stable water-in-oil emulsion system |
| 12/29/1997 | EP0813399A1 Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof |
| 12/29/1997 | EP0813396A1 Controlled dissolution pellet containing calcium sulfate |
| 12/29/1997 | EP0813365A1 Immunoisolation |
| 12/29/1997 | EP0750604B1 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes |
| 12/29/1997 | EP0665744B1 Stable extended release oral dosage composition |
| 12/29/1997 | EP0656775B1 Sustained release tablets containing bupropion |
| 12/29/1997 | EP0644719B1 Water-soluble, instant tea product |
| 12/29/1997 | EP0608357B1 Device for administering drug transdermally with a controlled temporal change in skin flux |
| 12/27/1997 | CA2207170A1 Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness |
| 12/26/1997 | CA2208802A1 Sustained release-preparation |
| 12/24/1997 | WO1997048485A1 Method for providing dense particle compositions for use in transdermal particle delivery |
| 12/24/1997 | WO1997048444A1 Iontophoretic delivery of cell adhesion inhibitors |
| 12/24/1997 | WO1997048443A1 Iontophoretic delivery of cell adhesion inhibitors |
| 12/24/1997 | WO1997048428A1 Adsorbent carrier used in direct hemoperfusion and method for reducing the particle size thereof |
| 12/24/1997 | WO1997048414A1 INSULIN PREPARATIONS CONTAINING NaCl |
| 12/24/1997 | WO1997048413A1 Insulin preparations containing carbohydrates |
| 12/24/1997 | WO1997048412A1 Long-acting galenical formulation for grf peptides |
| 12/24/1997 | WO1997048410A1 Cyclosporin-containing soft capsule preparations |
| 12/24/1997 | WO1997048398A1 Liposome preparations of indolocarbazole derivatives |
| 12/24/1997 | WO1997048395A1 Iontophoretic delivery of integrin inhibitors |
| 12/24/1997 | WO1997048387A1 Device for topical treatment of acne and its method of manufacture |
| 12/24/1997 | WO1997048386A1 Enteric coated diltiazem once-a-day formulation |
| 12/24/1997 | WO1997048385A2 Controlled release tablet |
| 12/24/1997 | WO1997048384A2 Marking rapidly disintegrating dosage forms |
| 12/24/1997 | WO1997048383A1 Biconvex rapidly disintegrating dosage forms |